What is the main purpose and function of the IPCL treatment method?

IPCL is an implantable contact lens treatment that corrects myopia and astigmatism by inserting a small lens into the eye.

What material is used to make the implantable contact lens (IPCL)?

It uses an acrylic polymer material primarily composed of HEMA, which is widely used in intraocular lenses.

How does the IPCL treatment differ from LASIK in terms of reversibility?

Unlike LASIK, IPCL does not involve shaving the cornea, making it highly reversible because the lens can be removed later.

When was IPCL approved and launched in Japan by the Ministry of Health, Labour and Welfare?

IPCL obtained regulatory approval in April 2025 and was officially launched in Japan in September of the same year.

What percentage of the survey subjects were aware of implantable contact lenses?

More than 70% (specifically 72.8%) of the survey subjects with vision of 0.1 or less were aware of the treatment method.

AI News NQ Analysis

Survey on Awareness of Implantable Contact Lenses (Phakic Posterior Chamber Lenses) Among Men and Women in Their 20s-40s with Vision of 0.1 or Less

NQ Score 50/100

AI Summary (NQ-processed)

At Working Co., Ltd., the Japanese distributor of "IPCL®," an implantable contact lens approved by the Ministry of Health, Labour and Welfare in April 2025, conducted a survey on implantable contact lenses among men and women in their 20s to 40s nationwide. The survey found that over 70% of respondents were aware of the treatment, with nearly the same percentage expressing interest. The primary drivers of interest were the inconvenience and ongoing cost of glasses and traditional contact lenses, while the main deterrents were fear of surgery and safety concerns. Interest was notably higher among women in their 20s and 30s.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the main purpose and function of the IPCL treatment method?: A: IPCL is an implantable contact lens treatment that corrects myopia and astigmatism by inserting a small lens into the eye.
Q: What material is used to make the implantable contact lens (IPCL)?: A: It uses an acrylic polymer material primarily composed of HEMA, which is widely used in intraocular lenses.
Q: How does the IPCL treatment differ from LASIK in terms of reversibility?: A: Unlike LASIK, IPCL does not involve shaving the cornea, making it highly reversible because the lens can be removed later.
Q: When was IPCL approved and launched in Japan by the Ministry of Health, Labour and Welfare?: A: IPCL obtained regulatory approval in April 2025 and was officially launched in Japan in September of the same year.
Q: What percentage of the survey subjects were aware of implantable contact lenses?: A: More than 70% (specifically 72.8%) of the survey subjects with vision of 0.1 or less were aware of the treatment method.